Purpose Graves’ ophthalmopathy (GO) is an autoimmune orbital inflammatory disease associated with Graves’ disease. It can cause vision loss, facial disfigurement, and reduced quality of life. Systemic corticosteroids remain the first-line treatment for moderate-to-severe GO, administered either orally or intravenously. However, the optimal route of administration remains uncertain, with ongoing debate regarding their comparative efficacy and safety.The aim of this review is to compare the efficacy and safety of intravenous versus oral corticosteroids in the treatment of moderate-to-severe GO.Methods Randomized controlled trials were included. Risk of bias was assessed using the Cochrane RoB 2 tool. Outcomes focused on efficacy and safety of intravenous versus oral glucocorticoids in the treatment of GO.Results Five eligible RCTs involving 288 patients were analyzed. Intravenous steroids appeared to improve the clinical activity score (MD = −0.57; 95% CI: −0.82 to −0.33; p < 0.00001) and reduce the risk of Cushingoid facial features (RR = 0.17; 95% CI: 0.08 to 0.35; p < 0.00001). However, limited efficacy was observed in diplopia, proptosis, and in minimizing other steroid-related adverse events.Conclusion IV steroids were associated with more favourable outcomes and better tolerability than oral steroids in moderate-to-severe GO. Further comprehensive trials are needed to confirm long-term safety and optimize treatment protocols.
Advanced Health Science and Technology Journal · مجلد 2 (1) · 47-52
Abstract Background: Healthcare providers in Saudi Arabia often neglect their personal health due to high occupational stress and cultural barriers. This study evaluates the Health-Related Quality of Life (HRQoL) among providers in Riyadh and identifies factors influencing their well-being. Methods: A cross-sectional study was conducted among 122 healthcare providers using the validated Arabic and English short form health survey (SF-36) between January and March 2025. Data were analyzed using SPSS v28, employing Kolmogorov-Smirnov tests for normality and Mann-Whitney U tests for group comparisons. Results: Males scored significantly higher in social functioning and emotional well-being ( P < 0.05). Physical functioning significantly decreased with age (p = 0.009). Conclusion: Demographic factors significantly impact HRQoL. Targeted institutional wellness initiatives are essential to support the healthcare workforce.
health-related quality of lifehealthcare workersoccupational stresshealthcare worker well-being
The incidence of suicide, self-harm, and mental crises among teenagers is rising, presenting significant global public health issues. Conventional clinical risk evaluations have inadequate predictive accuracy, often overlooking high-risk adolescents. Machine learning models employing electronic health records provide an innovative method for predicting mental health crises through the integration of intricate clinical data patterns. Hence, this review aims to comprehensively examine and synthesize information about machine learning models created using electronic health record data for predicting suicide attempts, self-harm, or mental hospitalization in teenagers. Adhering to Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) principles, we executed an exhaustive search across six databases (2000-2025) for peer-reviewed research utilizing machine learning algorithms on electronic health record data to predict adolescent mental health crises. The inclusion criteria emphasized structured or unstructured electronic health record inputs, teenage cohorts (ages 10-20), and performance indicators like area under the curve (AUC), sensitivity, or specificity. The Prediction Model Risk of Bias Assessment Tool (PROBAST) was utilized to evaluate the risk of bias. Our search yielded five studies (2019-2024) that satisfied the inclusion criteria. All studies were retrospective cohorts conducted in high-income nations. Structured electronic health record data (e.g., diagnoses, prescriptions) were frequently utilized; two studies included natural language processing. Machine learning models demonstrated moderate to high discrimination (AUC 0.68-0.88), exhibiting optimal performance in short-term suicide prediction with hybrid data inputs. All investigations, however, exhibited a significant risk of bias in the analysis domain owing to insufficient external validation and absent calibration data. The positive predictive values consistently remained modest across all models. Overall, machine learning models demonstrate potential for enhancing adolescent suicide risk classification utilizing electronic health record data, surpassing numerous traditional instruments. Nonetheless, issues of generalizability, ethical constraints, and implementation obstacles remain. Thorough validation, calibration, and equity assessments are necessary prior to incorporation into clinical practice.
adolescent mental healthsuicide risk predictionself-harmelectronic health records
Gut microbiome-targeted therapies have shown promise in promoting the outcomes of metabolic inflammation-related disease management. This review aims to assess the effectiveness of microbiome-targeted interventions and pinpoint the most promising therapies for clinical implementation. Following the PRISMA 2020 standards, we searched four main databases: PubMed, EMBASE, Scopus, and the Cochrane Library. We integrated medical subject headings (MeSH) and free-text keywords search pertinent to gut microbiome-targeted interventions, along with related outcomes such as inflammation and insulin resistance. English studies were conducted on primary adults with a metabolic disease diagnosis or deemed a high risk, and were mandated to report at least one outcome pertinent to metabolic health or systemic inflammation. To assess the risk bias, data were extracted, and the Cochrane Risk of Bias (RoB) 2.0 tool was employed. Fifteen studies fulfilled the inclusion criteria. A narrative synthesis was conducted. We found that probiotics significantly enhanced insulin resistance (HOMA-IR), reduced circulating endotoxin levels, decreased visceral fat, BMI, and fat mass, and increased beneficial taxa with obesity-associated bacteria reduction. However, inconsistent outcomes were shown for lipid parameters. Prebiotic therapies showed significant decreases in fasting glucose in overweight people, and insulin levels and HOMA-IR in patients with metabolic syndrome, enhanced anti-inflammatory effects (31% C-reactive protein (CRP) reduction, decreased interleukin (IL)-6, tumor necrosis factor-alpha (TNF)-α, and lipopolysaccharide (LPS) levels), and promoted butyrate-producing bacteria. Synbiotic interventions showed complementary benefits for glucose metabolism and body composition. Fecal microbiota transplantation (FMT) studies indicated improved insulin sensitivity and donor microbiota engraftment in responders. Fiber-rich diet trials markedly improved HbA1c levels in diabetic and prediabetic individuals. In conclusion, prebiotics demonstrated the most consistent metabolic and anti-inflammatory benefits across multiple parameters. Probiotics showed targeted effects on insulin resistance and body composition but inconsistent lipid outcomes. FMT and synbiotics require further investigation to establish clinical efficacy. This evidence supports prebiotics as a priority intervention for metabolic disease management through microbiome modulation.